Royal Bank of Canada Cuts Edgewise Therapeutics (NASDAQ:EWTX) Price Target to $52.00
Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report) had its price target lowered by research analysts at Royal Bank of Canada from $56.00 to $52.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Royal Bank of Canada’s price objective points to a […]
Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report) had its price target lowered by research analysts at Royal Bank of Canada from $56.00 to $52.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Royal Bank of Canada’s price objective points to a […]
